Overview

The Effect of Bevacizumab on the Trabeculectomy

Status:
Unknown status

Trial end date:
2012-03-01

Target enrollment:

Participant gender:

Summary

The investigators plan to evaluate the additive effect of intracameral and subconjunctival injections of bevacizumab in trabeculectomies with other antimetabolites.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Samsung Medical Center

Treatments:

Bevacizumab